Cover Image
Market Research Report

Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts

Published by Greystone Research Associates Product code 242925
Published Content info
Delivery time: 1-2 business days
Back to Top
Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts
Published: May 1, 2014 Content info:

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. Growth in this sector will be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.


  • Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market
  • Analyzes oral transmucosal drug products and pipeline product candidates
  • Provides assessments of key oral transmucosal drug therapeutic categories
  • Provides market data and forecasts to 2018
  • Profiles market participants, their product development activities and strategies

What You Will Learn

  • What are the key segments and patient demographics that comprise the market for oral transmucosal drug delivery?
  • What are the major therapeutic demand drivers for transmucosal drug products?
  • What are the design factors and technologies that are being used in commercial and development-stage transmucosal products?
  • What is the market share and product position in the market and what will it look like in 2018?
  • Who are the companies behind the current generation of transmucosal drugs and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging transmucosal products?
  • What is the impact of economic, technology, and regulatory factors?
Table of Contents
Product Code: TMC316K

Table of Contents

Executive Summary

Drug Delivery Market Dynamics

  • Evolution in Drug Development
  • Market and Demand Drivers
    • Shifting Patient Demographics
    • The Impact of Generics
    • Managed Care Initiatives
  • Competitive Landscape

Competing Transmucosal Delivery Technologies

  • Oral Sprays
  • Buccal Films and Tablets
  • Sublingual Films and Wafers

Commercial Transmucosal Formulation Platforms

Oral Transmucosal Drug Technology Factors

  • Absorption
  • Bioavailability
  • Adhesion
  • Pharmacokinetics

FDA-Approved Oral Transmucosal Products

  • Andrenergic Inhibitors
  • Antifungals
  • GABA Agonists
  • Hormones
  • Nitrates
  • Opioid Agonists
  • Psychotropic Agents
  • Serotonin 5-HT3 Inhibitors

Important Pipeline Product Candidates

Market Assessments & Forecasts

  • Addiction
  • Anti-infectives
  • Cardiology
  • Diabetes
  • Immunology
  • Infectious Disease
  • Neurology
  • Oncology
  • Pain Management
  • Sexual Health
  • Vaccines

Market Factors

  • Formulations and Proprietary Platforms
  • Government Regulations Patent
  • Expiration and Rx-to-OTC Switching

Market Participant Profiles

Back to Top